首页> 外文期刊>Microarrays >MicroRNA Profile of Lung Tumor Tissues Is Associated with a High Risk Plasma miRNA Signature
【24h】

MicroRNA Profile of Lung Tumor Tissues Is Associated with a High Risk Plasma miRNA Signature

机译:肺肿瘤组织的MicroRNA配置文件与高风险血浆miRNA签名相关联

获取原文
       

摘要

Lung cancer is the most common cause of cancer deaths worldwide. MicroRNAs (miRNAs) are short, non-coding RNAs that regulate gene expression. Many studies have reported that alterations in miRNA expression are involved in several human tumors. We have previously identified a circulating miRNA signature classifier (MSC) able to discriminate lung cancer with more aggressive features. In the present work, microarray miRNA profiling of tumor tissues collected from 19 lung cancer patients with an available MSC result were perform in order to find a possible association between miRNA expression and the MSC risk level. Eleven tissue mature miRNAs and six miRNA precursors were observed to be associated with the plasma MSC risk level of patients. Not one of these miRNAs was included in the MSC algorithm. A pathway enrichment analysis revealed a role of these miRNA in the main pathways determining lung cancer aggressiveness. Overall, these findings add to the knowledge that tissue and plasma miRNAs behave as excellent diagnostic and prognostic biomarkers, which may find rapid application in clinical settings.
机译:肺癌是全世界癌症死亡的最常见原因。微小RNA(miRNA)是调节基因表达的短的非编码RNA。许多研究报告说,miRNA表达的改变与几种人类肿瘤有关。我们之前已经确定了一种循环miRNA特征分类器(MSC),能够区分具有更具侵略性的肺癌。在本工作中,对从19名肺癌患者中获得的可用MSC结果收集的肿瘤组织进行微阵列miRNA分析,以发现miRNA表达与MSC风险水平之间的可能联系。观察到11个组织成熟的miRNA和6个miRNA前体与患者血浆MSC风险水平相关。这些miRNA中没有一个包含在MSC算法中。途径富集分析揭示了这些miRNA在决定肺癌侵袭性的主要途径中的作用。总体而言,这些发现增加了对组织和血浆miRNA表现为出色的诊断和预后生物标志物的认识,可在临床环境中快速应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号